- Home
- LNC vs ALKS Comparison
LNC vs ALKS Comparison
Compare LNC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNC
- ALKS
- Stock Information
- Founded
- LNC 1905
- ALKS 1987
- Country
- LNC United States
- ALKS Ireland
- Employees
- LNC N/A
- ALKS N/A
- Industry
- LNC Life Insurance
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- LNC Finance
- ALKS Health Care
- Exchange
- LNC Nasdaq
- ALKS Nasdaq
- Market Cap
- LNC 5.5B
- ALKS 4.5B
- IPO Year
- LNC N/A
- ALKS 1991
- Fundamental
- Price
- LNC $34.07
- ALKS $30.72
- Analyst Decision
- LNC Hold
- ALKS Buy
- Analyst Count
- LNC 11
- ALKS 12
- Target Price
- LNC $36.27
- ALKS $38.33
- AVG Volume (30 Days)
- LNC 2.0M
- ALKS 1.8M
- Earning Date
- LNC 05-08-2025
- ALKS 05-01-2025
- Dividend Yield
- LNC 5.22%
- ALKS N/A
- EPS Growth
- LNC N/A
- ALKS N/A
- EPS
- LNC 7.17
- ALKS 2.09
- Revenue
- LNC $18,544,000,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- LNC $5.74
- ALKS N/A
- Revenue Next Year
- LNC $2.74
- ALKS $4.09
- P/E Ratio
- LNC $4.81
- ALKS $14.69
- Revenue Growth
- LNC 54.56
- ALKS N/A
- 52 Week Low
- LNC $27.58
- ALKS $22.90
- 52 Week High
- LNC $39.85
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- LNC 54.52
- ALKS 54.63
- Support Level
- LNC $33.20
- ALKS $30.38
- Resistance Level
- LNC $35.70
- ALKS $31.56
- Average True Range (ATR)
- LNC 0.84
- ALKS 0.98
- MACD
- LNC 0.37
- ALKS 0.28
- Stochastic Oscillator
- LNC 64.61
- ALKS 71.00
About LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.